EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Box–Behnken Design Optimization of High-Pressure Processed Bitter Melon (Momordica charantia) Leaf Extract Enhancing Phytochemicals, Anticancer, and Anti-Inflammatory Activities

Kongsakon Kulchim iD, Sukan Braspaiboon iD, Pornsiri Pitchakarn iD, Arisa Imsumran iD, Pensiri Buacheen iD, Tanongsak Laowanitwattana iD, Piya Temviriyanukul iD, Kongthawat Chairatvit, Ariyaphong Wongnoppavich iD

International Journal of Molecular Sciences · 29.05.2026 · 27 (11) · 4945

DOI: 10.3390/ijms27114945 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.05.2026. Verfasst von Kongsakon Kulchim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate/Ph.D. Program in Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand. Hauptthemen laut MEDLINE: Momordica charantia, Plant Extracts, Anti-Inflammatory Agents, Plant Leaves. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Council of Thailand, Faculty of Medicine Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bitter Melon Leaf Extract (BMLE) possesses potential anticancer and anti-inflammatory properties; however, conventional extraction methods restrict phytochemical yield and bioactivity. Here, we optimized extraction using High-Pressure Processing (HPP) with Box–Behnken Design (BBD) and Response Surface Methodology (RSM). The optimized extract (O-BMLE) demonstrated significantly higher total flavonoid content (27.7 vs. 8.7 mg RE/g) and FRAP antioxidant capacity (96.5 vs. 71.2 μmol TE/g) compared to conventional BMLE. Additionally, O-BMLE exhibited enhanced cytotoxicity (A549 IC50: 58.7 vs. 147 μg/mL) and selectivity (SI: 5.03 vs. 2.60) against A549, HepG2, and SKOV3 cancer cells while showing minimal effects on 3T3-L1 fibroblasts. In LPS-stimulated RAW264.7 macrophages, O-BMLE selectively inhibited JNK phosphorylation without affecting NF-κB phosphorylation, resulting in suppression of iNOS, COX-2, IL-1β, IL-6, and TNF-α expression as well as nitric oxide production. HPLC analysis revealed equivalent momordicine-I levels (~28 mg/g) between extracts. In contrast, HPLC-qTOF-MS profiling revealed that O-BMLE was enriched in stearidonic acid (66% increase in relative abundance), 4-hydroxybenzoic acid (19.5%), monolinolenin, 6-gingerol, and pedunculoside, which are compounds linked to JNK inhibition, antioxidant activity, and cytokine suppression. These results indicate that HPP-BBD/RSM optimization selectively modifies the bitter melon leaf metabolome, thereby enhancing anticancer and anti-inflammatory activities independently of momordicine-I content alone. O-BMLE may therefore serve as a promising candidate for the development of functional foods and nutraceuticals targeting inflammation-associated cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Momordica charantiaPlant ExtractsAnti-Inflammatory AgentsPlant LeavesPhytochemicalsAntineoplastic AgentsHumansMiceAnimalsRAW 264.7 CellsCell Line, TumorAntioxidantsNF-kappa BMacrophages

Stichwörter der Autor:innen

JNK signalingMomordica charantiaanti-inflammationanticancerhigh-pressure processingnon-thermal extractionphytometabolomicsresponse surface methodology

Substanzen

Plant ExtractsAnti-Inflammatory AgentsPhytochemicalsAntioxidantsAntineoplastic AgentsNF-kappa B

Autor:innen und Institutionen

  • Graduate/Ph.D. Program in Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Faculty of Agro-Industry, Chiang Mai University, Chiang Mai 50100, Thailand.
  • Institute of Nutrition, Mahidol University, Salaya, Nakhon Pathom 73170, Thailand.
  • Department of Oral Biology, Faculty of Dentistry, Mahidol University, Bangkok 10400, Thailand.

ORCID-Profile: Kongsakon Kulchim, Sukan Braspaiboon, Pornsiri Pitchakarn, Arisa Imsumran, Pensiri Buacheen, Tanongsak Laowanitwattana, Piya Temviriyanukul, Ariyaphong Wongnoppavich

Förderung

  • National Research Council of Thailand
  • Faculty of Medicine Research Fund

Zitieren

APA

Kulchim, K., Braspaiboon, S., Pitchakarn, P., Imsumran, A., Buacheen, P., Laowanitwattana, T., Temviriyanukul, P., Chairatvit, K., & Wongnoppavich, A. (2026). Box–Behnken Design Optimization of High-Pressure Processed Bitter Melon (Momordica charantia) Leaf Extract Enhancing Phytochemicals, Anticancer, and Anti-Inflammatory Activities. International Journal of Molecular Sciences, 27(11), 4945. https://doi.org/10.3390/ijms27114945

Vancouver

Kulchim K, Braspaiboon S, Pitchakarn P, Imsumran A, Buacheen P, Laowanitwattana T, et al. Box–Behnken Design Optimization of High-Pressure Processed Bitter Melon (Momordica charantia) Leaf Extract Enhancing Phytochemicals, Anticancer, and Anti-Inflammatory Activities. International Journal of Molecular Sciences. 2026;27(11):4945. doi:10.3390/ijms27114945

BibTeX
@article{Kulchim2026,
  author = {Kulchim, Kongsakon and Braspaiboon, Sukan and Pitchakarn, Pornsiri and Imsumran, Arisa and Buacheen, Pensiri and Laowanitwattana, Tanongsak and Temviriyanukul, Piya and Chairatvit, Kongthawat and Wongnoppavich, Ariyaphong},
  title = {Box–Behnken Design Optimization of High-Pressure Processed Bitter Melon (Momordica charantia) Leaf Extract Enhancing Phytochemicals, Anticancer, and Anti-Inflammatory Activities},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {11},
  pages = {4945},
  doi = {10.3390/ijms27114945}
}
Kostenlos starten →